Yellow Fever Treatment Market Size, Share Global Forecast to 2031Posted by pooja on August 29th, 2022  Yellow fever is essentially a mosquito-borne disease, which is more prevalent in African countries as well as in Central and South American region. Often, these diseases are transmitted across the countries via infected travelers, but it is more frequent in countries wherein the mosquito species are able to flourish in a region’s specific climatic conditions and the animal pool required to maintain their prosperity. Yellow fever is caused by a virus transferred through infected Aedes aegypti mosquitoes. These mosquitoes thrive near human dwellings and breed in clean waters. The occurrence of yellow fever is more prevalent in sub-Saharan Africa and tropical South America. Humans and monkeys represent the target patient population infected with yellow fever virus. The prevention of yellow fever is essential and vaccination is advised for children above 9 months of age. These vaccines are usually administered by travel medicine clinics and local or state health departments and needs to be repeated every 10 years for individuals who travel frequently to high risk African and Latin American countries. Individuals with compromised immune system or cancer patient, pregnant women, and children below 9 months of age are recommended not to take yellow fever vaccine. Get Sample Copy Of This Report: https://www.tmrresearch.com/sample/sample?flag=B&rep_id=65 About TMR Research Contact: Like it? Share it! More by this author |